<DOC>
	<DOCNO>NCT00742339</DOCNO>
	<brief_summary>From 1999 , several study show use vasoconstrictor association albumin effective treatment hepatorenal syndrome ( HRS ) . The rationale use vasoconstrictor together albumin treatment severe complication portal hypertension patient cirrhosis correct reduction effective circulating volume due splanchnic arterial vasodilatation.In study terlipressin , derivate vasopressin , use vasoconstrictor intravenous bolus move initial dose 0.5-1 mg/4 hr . In study midodrine , alpha-adrenergic agonist , give mouth use vasoconstrictor dose range 2.5 12.5 tid together octreotide , inhibitor release glucagon , give subcutaneously dose range 10 µg upt 200 µg tid . To day , n't study compare terlipressin + albumin versus midodrine + octreotide + albumin treatment HRS patient cirrhosis.Thus , aim study compare terlipressin + albumin v midodrine + octreotide + albumin treatment HRS patient cirrhosis .</brief_summary>
	<brief_title>Terlipressin + Albumin Versus Midodrine + Octreotide Treatment Hepatorenal Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>Patients cirrhosis diagnosis HRS type 1 2 , serum creatinine &gt; 2.5 mg/dl Diagnosis HCC stag beyond Milan Criteria di Milano Septic shock ( systolic arterial pressure &lt; 90 mmHg Significant heart respiratory failure Peripheral arteriophaty clinically significant Previous heart stroke significant alteration ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>hepatorenal syndrome</keyword>
	<keyword>terlipressin</keyword>
	<keyword>midodrine</keyword>
	<keyword>octreotide</keyword>
	<keyword>human albumin</keyword>
	<keyword>effective circulating volume</keyword>
	<keyword>The criterion use diagnosis HRS criterion recently publish International Ascites Club</keyword>
	<keyword>Patients cirrhosis type 2 HRS serum creatinine value &gt; 2.5 mg/dl</keyword>
	<keyword>All patient cirrhosis type 1 HRS</keyword>
</DOC>